Anti-PD-L1 Monoclonal Antibody Clinical Trials
3 recruitingBiologic
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Stage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Lung Non-Small Cell Carcinoma
City of Hope Medical Center535 enrolled13 locationsNCT07288034
Recruiting
Phase 2
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
Hematopoietic and Lymphatic System NeoplasmAdvanced Malignant Solid Neoplasm
Yuanquan Yang40 enrolled1 locationNCT06470971
Recruiting
Phase 2
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
Colon Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05914389